> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Info Collection Extension for Review Transparency
- URL: https://www.fdaweb.com/info-collection-extension-for-review-transparency/
- Published: 2019-08-19T12:00:00.000Z
- Updated: 2026-09-15T01:44:36.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5144794

*Federal Register* notice: FDA has submitted to OMB an information collection extension for “Evaluation of the Program for Enhanced Review Transparency and Communication for New Molecular Entity New Drug Applications and Original Biologics License Applications in Prescription Drug User Fee Acts and 351(k) Biologics License Applications in Biosimilars User Fee Act” (OMB Control Number 0910-0746). To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2019-08-19/pdf/2019-17713.pdf?ref=fdaweb.com).